Following on from my previous post on Urine Testing for Breast Cancer... Hitachi is now moving forward to develop a scalable solution in collaboration with Hirotsu Bio Science. Excited to see this moving forward!
Hitachi, Ltd. (TSE: 6501, Hitachi) and Hirotsu Bio Science Inc. (HirotsuBio) have entered an agreement to collaborate on research for the practical application of cancer screening using nematodes. The two companies will conduct collaborative research to realize the practical application of HirotsuBio's "N-NOSE" cancer screening method using nematodes by automating the test process employing the new technology developed by Hitachi to automate the analysis of cancer tests using nematodes. This research will enable the large-scale testing required for future clinical assessment and thus, contribute to the early detection of cancer.